MYRIAD GENETICS INC (MYGN) Form 8-K — Jun 23, 2026
Myriad Genetics disclosed that Daniel M. Skovronsky M.D., Ph.D. resigned from the company's Board of Directors effective immediately on June 17, 2026. The company noted that Dr.
Price after filing
1 day: +12.7%7 days: +23.3%30 days: +22.2%
Close on the filing date to close N calendar days later (from $4.63). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.